Cytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M
PremiumThe FlyCytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M
1M ago
Cytek Biosciences sees FY25 revenue $204M-$212M, consensus $216.52M
Premium
The Fly
Cytek Biosciences sees FY25 revenue $204M-$212M, consensus $216.52M
1M ago
Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs
Premium
The Fly
Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs
2M ago
Cytek Biosciences sees FY24 revenue $200M-$201M, consensus $204.71M
PremiumThe FlyCytek Biosciences sees FY24 revenue $200M-$201M, consensus $204.71M
3M ago
Cytek Biosciences board approves $50M stock repurchase program
Premium
The Fly
Cytek Biosciences board approves $50M stock repurchase program
3M ago
Cytek Biosciences price target raised to $8.50 from $8 at Piper Sandler
Premium
The Fly
Cytek Biosciences price target raised to $8.50 from $8 at Piper Sandler
5M ago
CTKB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCTKB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Cytek Biosciences announces resignation of Chief Operating Officer
Premium
The Fly
Cytek Biosciences announces resignation of Chief Operating Officer
7M ago
Cytek Biosciences COO Resigns, Signaling Leadership Changes
Premium
Company Announcements
Cytek Biosciences COO Resigns, Signaling Leadership Changes
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100